TMA Master publication list

1.    Alberghini, M., Kliskey, K., Krenacs, T., Picci, P., Kindblom, L., Forsyth, R., and Athanasou, N.A. (2010).
Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.
Virchows Arch. 456, 97–103.

2.    Balla, P., Moskovszky, L., Sapi, Z., Forsyth, R., Knowles, H., Athanasou, N.A., Szendroi, M., Kopper, L., Rajnai, H., Pinter, F., et al. (2011).
Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
Histopathology 59, 376–389.

3.    Bignotti, E., Zanotti, L., Calza, S., Falchetti, M., Lonardi, S., Ravaggi, A., Romani, C., Todeschini, P., Bandiera, E., Tassi, R.A., et al. (2012).
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.
BMC Clin. Pathol. 12, 22.

4.    Chaisuparat, R., Yodsanga, S., Montaner, S., and Jham, B.C. (2013).
Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 116, 336–342.

5.    Chang, H., Peluso, D., Hussain, S., Shipitsin, M., and Blume-Jensen, P. (2014).
Optimizing tissue microarray construction procedure to improve quality of sections.
J. Histotechnol. 37, 95–100.

6.    Francz, M., Egervari, K., Kardos, L., Toth, J., Nemes, Z., Szanto, J., and Szollosi, Z. (2010).
Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.
J. Clin. Pathol. 63, 341–346.

7.    Giorgio, E.D., Clocchiatti, A., Piccinin, S., Sgorbissa, A., Viviani, G., Peruzzo, P., Romeo, S., Rossi, S., Tos, A.P.D., Maestro, R., et al. (2013).
MEF2 Is a Converging Hub for Histone Deacetylase 4 and Phosphatidylinositol 3-Kinase/Akt-Induced Transformation.
Mol. Cell. Biol. 33, 4473–4491.

8.    Goos, J. a. C.M., Coupe, V.M.H., Diosdado, B., Delis-Van Diemen, P.M., Karga, C., Beliën, J. a. M., Carvalho, B., van den Tol, M.P., Verheul, H.M.W., Geldof, A.A., et al. (2013).
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
Br. J. Cancer 109, 2445–2452.

9.    Goos, J.A.C.M., de Cuba, E.M.V., Coupé, V.M.H., Diosdado, B., Delis-Van Diemen, P.M., Karga, C., Beliën, J.A.M., Menke-Van der Houven van Oordt, C.W., Geldof, A.A., Meijer, G.A., et al. (2015).
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis:
Ann. Surg. 1.

10.    De Graaff, M.A., Cleton-Jansen, A.-M., Szuhai, K., and Bovée, J.V.M.G. (2013).
Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
Hum. Pathol. 44, 1597–1604.

11.    Krenacs, T., Ficsor, L., Varga, S.V., Angeli, V., and Molnar, B. (2010).
Digital Microscopy for Boosting Database Integration and Analysis in TMA Studies.
In Tissue Microarrays, R. Simon, ed. (Humana Press), pp. 163–175.

12.    Laurinavicius, A., Laurinaviciene, A., Ostapenko, V., Dasevicius, D., Jarmalaite, S., and Lazutka, J. (2012).
Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Diagn. Pathol. 7, 27.

13.    Meijer, D., Gelderblom, H., Karperien, M., Cleton-Jansen, A.-M., Hogendoorn, P.C., and Bovée, J.V. (2011).
Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo.
Clin. Sarcoma Res. 1, 5.

14.    Ohtomo, R., Mori, T., Shibata, S., Tsuta, K., Maeshima, A.M., Akazawa, C., Watabe, Y., Honda, K., Yamada, T., Yoshimoto, S., et al. (2013).
SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Mod. Pathol. 26, 1041–1050.

15.    Van Oosterwijk, J.G., Meijer, D., van Ruler, M.A.J.H., van den Akker, B.E.W.M., Oosting, J., Krenács, T., Picci, P., Flanagan, A.M., Liegl-Atzwanger, B., Leithner, A., et al. (2013).
Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets.
Am. J. Pathol. 182, 1347–1356.

16.    Rajnai, H., Bödör, C., Balogh, Z., Gagyi, É., Csomor, J., Krenács, T., Tóth, E., and Matolcsy, A. (2012).
Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.
Histopathology60, E66–E75.

17.    Rossing, H.H., Talman, M.-L.M., Lænkholm, A.-V., and Wielenga, V.T. (2012).
Implementation of TMA and digitalization in routine diagnostics of breast pathology.
APMIS 120, 341–347.

18.    Tamás, L., Szentkúti, G., Erős, M., Dános, K., Brauswetter, D., Szende, B., Zsákovics, I., and Krenács, T. (2011).
Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization.
Pathol. Oncol. Res. 17, 721–727.

19.    Hajnalka Rajnai, Ivett Teleki, Gergo Kiszner, Nora Meggyesházi, Peter Balla, Tamas Vancsik, Györgyi Műzes,Judit Csomor, András Matolcsy, and Tibor Krenács (2014).
Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas.
J. of Immunology Res. In Press

20.    Butz, H., Németh, K., Czenke, D., Likó, I., Czirják, S., Zivkovic, V., Baghy, K., Korbonits, M., Kovalszky, I., Igaz, P., et al. (2016).
Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Pathol. Oncol. Res. 1–9.

21. Adriaens, C., Standaert, L., Barra, J., Latil, M., Verfaillie, A., Kalev, P., Boeckx, B., Wijnhoven, P.W.G., Radaelli, E., Vermi, W., et al. (2016). p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat. Med. 22, 861–868.

See full TMA Grand Master publication list